Abstract
Objective
The goal of this study was to establish the benefits and prognostic factors of lumbar dorsal ramus block (DRB) for low back pain.
Methods
A retrospective analysis was done with the data obtained from 344 patients with low back pain. The lumbar dorsal rami of L3, 4, 5 were blocked with 0.5% bupivacaine hydrochloride and methylprednisolone acetate. Visual analogue scale (VAS) was evaluated at 2 weeks, 1 month and 3 months and compared with pretreatment values. It was considered to be successful when the VAS grade at 3 months was improved more than 50%.